The Oxford Innovation Society event, organised by Oxford University Innovation (OUI) and sponsored by the NIHR Oxford Biomedical Research Centre, included fascinating presentations from a range of Oxford academics and company CEOs.
Sarah Walker, Professor of Medical Statistics and Epidemiology (Nuffield Department of Medicine), urged people to consider antimicrobial resistance as seriously as the climate crisis; and Professor Christopher Buckley, Director of Clinical Research at the Kennedy Institute of Rheumatology, called for a periodic table for medical scientists and physicians.
The story of the SpyBiotech’s protein superglue, an innovation spun out from the Oxford’s Department of Biochemistry, was told by its SEO Mark Leuchtenberger. Other speakers included Dr Cheerag Shirodaria, CEO of Oxford spinout Caristo Diagnostics, who presented the company’s advancements in revolutionising diagnosis and treatment of cardiovascular disease.
Over 100 OIS members, which included researchers and inventors, Oxford spinouts, technology transfer professionals, local companies, and venture capitalists, were given extensive networking opportunities and dinner in Pembroke’s historic dining hall.
Dr Simon Warner, OUI’s Head of Licensing and Ventures for Life Sciences, said: “It’s wonderful to be able to host our second OIS in person again after the pandemic. Our members benefit hugely from face-to-face networking and this evening’s presentations, from the NIHR BRC and leaders in Oxford’s innovation ecosystem, have been informative and thought provoking.”
The next OIS dinner will take place on the 23rd of March. In addition to exclusive events, OIS members can benefit from advanced notification of new technologies available for licence and are provided with a range of opportunities to promote their work or business. Find out more about membership.